Combining reverse end-to-side neurorrhaphy with rapamycin treatment on chronically denervated muscle in rats

J Integr Neurosci. 2021 Jun 30;20(2):359-366. doi: 10.31083/j.jin2002035.

Abstract

This preliminary research determines whether a combination of reverse end-to-side neurorrhaphy and rapamycin treatment achieves a better functional outcome than a single application after prolonged peripheral nerve injury. We found that the tibial nerve function of the reverse end-to-side + rapamycin group recovered better, with a higher tibial function index value, higher amplitude recovery rate, and shorter latency delay rate (P < 0.05). The reverse end-to-side + rapamycin group better protected the gastrocnemius muscle with more forceful contractility, tetanic tension, and a higher myofibril cross-sectional area (P < 0.05). Combining reverse end-to-side neurorrhaphy with rapamycin treatment is a practical approach to promoting the recovery of chronically denervated muscle atrophy after peripheral nerve injury.

Keywords: Muscle denervation; Nerve regeneration; Peripheral nerve injury; Rapamycin; Reverse end-to-side neurorrhaphy.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacology*
  • Combined Modality Therapy
  • Disease Models, Animal
  • Electromyography
  • Female
  • Muscle Denervation
  • Muscle, Skeletal / physiopathology*
  • Nerve Regeneration / physiology*
  • Neurosurgical Procedures*
  • Peripheral Nerve Injuries / drug therapy
  • Peripheral Nerve Injuries / surgery
  • Peripheral Nerve Injuries / therapy*
  • Rats
  • Rats, Sprague-Dawley
  • Sirolimus / administration & dosage
  • Sirolimus / pharmacology*
  • Tibial Neuropathy / drug therapy
  • Tibial Neuropathy / surgery
  • Tibial Neuropathy / therapy*

Substances

  • Anti-Bacterial Agents
  • Sirolimus